Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| P30DK092949 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Northwestern University | OTHER |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NIH |
| University of Chicago | OTHER |
Not provided
Not provided
Not provided
Patient populations at community health centers, specifically Black or African American and Hispanic or Latino populations with Type 2 diabetes, experience significant health disparities. In particular, they have higher rates of diabetes-related complications and other related conditions such as myocardial infarction, cerebrovascular disease, kidney failure, blindness, neuropathy, and the risk of amputation. Diabetes affects 34 million adults in the US. Achieving a target HbA1c less than 8% can be challenging through diabetes management. Patients are able to monitor their blood glucose levels with devices such as blood glucose meters or continuous glucose monitors to facilitate diabetes management and glycemic control. Past studies have demonstrated that these devices are effective in engaging patients in the improvement of diabetes management. Current advancements in remote patient monitoring and self-monitoring have been observed to be effective in facilitating improvement in diabetes outcomes. However, the effectiveness and financial feasibility of these devices delivered in conjunction with automated patient engagement systems in remote patient monitoring programs is not well understood among underinsured, underserved, and vulnerable minority populations as they face a high-cost barrier particularly with continuous glucose monitors. To better address this gap in knowledge, this pilot study will compare and examine the effectiveness of these interventions on patient outcomes with Type 2 diabetes among populations in the West Side of Chicago. Study the comparative effectiveness among patients with uncontrolled Type 2 diabetes on insulin in an intervention group using remote patient monitoring and automated patient engagement system with blood glucose monitors to a group using a self-monitoring program with continuous glucose monitors and a usual care group receiving standard care. Conduct a feasibility analysis and financial impact of these programs among an underinsured and underserved population of Black/African Americans or Hispanic/Latinos with Type 2 diabetes.
This will be conducted at a Lawndale Christian Health Center, a community health center in the West Side of Chicago that serves a largely Black or African American and Hispanic or Latino population. To accomplish this objective, Aim 1 will study the impact on patients with uncontrolled Type 2 diabetes on insulin by comparing an intervention group that features remote patient monitoring with an automated patient engagement system and health coaching using blood glucose meters compared to a group that features a self-monitoring program using continuous glucose monitoring devices and a usual care group with standard care, and Aim 2 will examine the feasibility of implementing these interventions and financial impact of each treatment group at a community health center. To understand the effect of this study on health outcomes, patient level data will be examined including primary outcomes for health measurements such as HbA1c, blood glucose, BMI/weight, estimated glomerular filtration rate (eGFR), patient-reported outcomes including medication adherence, daily activities, diabetes self-management activities, and secondary outcomes for health measurements such as LDL cholesterol, systolic and diastolic blood pressures, as well as implementation outcomes such as acceptability, appropriateness, and feasibility. The costs of implementation and delivery will be examined using a budget impact analysis. This study will be essential for informing the impact on health disparities through remote monitoring with automated patient engagement compared to self-monitoring when providing care for underinsured and underserved populations.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Remote patient monitoring and automated patient engagement system with blood glucose monitors | Experimental | Participants in this group will receive blood glucose monitors and will check their blood glucose daily with monitoring through a digital platform and provided health coaching. |
|
| Self-monitoring program with continuous glucose monitors | Experimental | Participants in this group will receive continuous glucose monitors and will self monitor their blood glucose measurements with support by their care team. |
|
| Usual care group receiving standard care | Active Comparator | Participants in this group will receive standard care for diabetes. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Blood glucose monitor with Digital Platform and Health Coaching | Device | Blood glucose monitors will be used daily to measure blood glucose measurements. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Glycated Hemoglobin | HbA1c based on blood sugar attached to hemoglobin based on lab analysis of blood. | Baseline and at 4 Months |
| Blood Glucose | Blood glucose measurements based blood glucose monitor (BGM) and continuous glucose monitor (CGMs). | 4 Months |
| Engagement with digital platform with a daily submission of blood glucose | Daily blood glucose measurements from blood glucose monitor submitted to the digital platform | 4 Months |
| Implementation - Acceptability of Intervention Measure (AIM) | Self-reported perception among patients that this service is agreeable, palatable, or satisfactory with a likert scale of disagree to agree. | Baseline and at 4 Months |
| Implementation - Intervention Appropriateness Measure (IAM) | Self-reported perception among patients that this service is fit, relevant, and compatible with a likert scale of disagree to agree. | Baseline and at 4 Months |
| Implementation - Feasibility of Intervention Measure (FIM) | Self-reported perception among patients that this service is successfully used or carried out within a primary care setting with a likert scale of disagree to agree. | Baseline and at 4 Months |
| The Diabetes Self-Management Questionnaire (DSMQ) on eating, medication, glucose monitoring, physical activity, and healthcare use |
| Measure | Description | Time Frame |
|---|---|---|
| Weight | Weight in pounds | Baseline and at 4 Months |
| Height | Height in inches | Baseline and at 4 Months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Andrew Wang | Lawndale Christian Health Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Lawndale Christian Health Center | Chicago | Illinois | 60623 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33411424 | Background | Weinstock RS, Aleppo G, Bailey TS, Bergenstal RM, Fisher WA, Greenwood DA, Young LA. The Role of Blood Glucose Monitoring in Diabetes Management. Arlington (VA): American Diabetes Association; 2020 Oct. Available from http://www.ncbi.nlm.nih.gov/books/NBK566165/ | |
| 23937988 | Background | Schmitt A, Gahr A, Hermanns N, Kulzer B, Huber J, Haak T. The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes. 2013 Aug 13;11:138. doi: 10.1186/1477-7525-11-138. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Continuous glucose monitor | Device | Continuous glucose monitors will be used daily to measure blood glucose measurements. |
|
|
| Usual Care | Other | Usual care for type 2 diabetes |
|
Self-reported perception among patients of eating behavior, medication adherence, glucose monitoring, physical activity, and healthcare use with a likert scale of applies to me very much, applies to me a considerable degree, applies to some degree, and does not apply to me. |
| Baseline and at 4 Months |
| Estimated glomerular filtration rate | The eGFR based on blood test. | Baseline and at 4 Months |
| Low-density lipoprotein Cholesterol | The LDL cholesterol based on blood test. | Baseline and at 4 Months |
| Blood Pressure | The systolic and diastolic blood pressure using blood pressure monitor. | Baseline and at 4 Months |
| Clinic Visit | The total count of clinic visits both virtually and on-site. | 4 Months |
| Hospitalizations | The total count of hospital admissions. | 4 Months |
| Costs of Implementation | Total estimated costs of implementing interventions using a budget impact analysis | 4 Months |
| 28851459 | Background | Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3. |
| D004700 | Endocrine System Diseases |